NL6703314A - - Google Patents

Info

Publication number
NL6703314A
NL6703314A NL6703314A NL6703314A NL6703314A NL 6703314 A NL6703314 A NL 6703314A NL 6703314 A NL6703314 A NL 6703314A NL 6703314 A NL6703314 A NL 6703314A NL 6703314 A NL6703314 A NL 6703314A
Authority
NL
Netherlands
Application number
NL6703314A
Other versions
NL152845B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6703314A publication Critical patent/NL6703314A/xx
Publication of NL152845B publication Critical patent/NL152845B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/90—Xanthenes with hydrocarbon radicals, substituted by amino radicals, directly attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL676703314A 1966-03-11 1967-02-28 Werkwijze voor het bereiden van een geneesmiddel met een psychotrope en bloedsomloopstimulerende werking, alsmede het aldus verkregen gevormde geneesmiddel, en werkwijze voor het bereiden van een geneeskrachtig omega,omega-difenylalkylaminederivaat. NL152845B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0086165 1966-03-11

Publications (2)

Publication Number Publication Date
NL6703314A true NL6703314A (fr) 1967-09-12
NL152845B NL152845B (nl) 1977-04-15

Family

ID=6983250

Family Applications (1)

Application Number Title Priority Date Filing Date
NL676703314A NL152845B (nl) 1966-03-11 1967-02-28 Werkwijze voor het bereiden van een geneesmiddel met een psychotrope en bloedsomloopstimulerende werking, alsmede het aldus verkregen gevormde geneesmiddel, en werkwijze voor het bereiden van een geneeskrachtig omega,omega-difenylalkylaminederivaat.

Country Status (6)

Country Link
AT (1) AT272306B (fr)
CH (1) CH499487A (fr)
FI (1) FI52335C (fr)
FR (1) FR1513909A (fr)
GB (1) GB1129029A (fr)
NL (1) NL152845B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130988C (fr) 1966-07-21 Boehringer Mannheim Gmbh
DE3009034A1 (de) * 1980-03-08 1981-09-24 Basf Ag, 6700 Ludwigshafen 10-substituierte 5-cyanmethylendibenzo (a,d) -cycloheptne
DE3009045A1 (de) 1980-03-08 1981-09-24 Basf Ag, 6700 Ludwigshafen 10-substituierte 5-cyanmethylen-10,11-dihydro-dibenzo-(a,d) -cycloheptene
FR2512024A1 (fr) * 1981-08-27 1983-03-04 Adir Ethers tricycliques, leur preparation et les compositions pharmaceutiques les contenant
DE3689688T2 (de) * 1985-10-15 1994-08-25 Abbott Lab Verbindungen und Immunoassay für tricyclische Antidepressiva.
US6750244B2 (en) * 1993-02-08 2004-06-15 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6017965A (en) * 1993-02-08 2000-01-25 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6211245B1 (en) 1993-02-08 2001-04-03 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US7087765B2 (en) 1995-06-07 2006-08-08 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
WO1998056752A1 (fr) * 1997-06-11 1998-12-17 Nps Pharmaceuticals, Inc. Composes actifs sur un nouveau site des canaux calciques actives par les recepteurs servant au tratitement des troubles et des maladies neurologiques
US6919473B2 (en) * 2002-09-17 2005-07-19 Cph Innovations Corporation Photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
US7534420B2 (en) 2004-02-25 2009-05-19 Hallstar Innovations Corp. Compounds derived from polyanhydride resins with film-forming, UV-absorbing, and photostablizing properties, compositions containing same, and methods of using the same
US7235587B2 (en) 2004-07-01 2007-06-26 Cph Innovations Corporation Diesters containing two crylene or fluorene moieties, sunscreen compositions containing the same, and methods of photostabilizing a sunscreen compositions containing the same
US8158678B2 (en) 2005-04-07 2012-04-17 Cph Innovations Corp. Photoabsorbing, highly conjugated compounds of cyanoacrylic esters, sunscreen compositions and methods of use
US10930937B2 (en) * 2016-11-23 2021-02-23 Lockheed Martin Energy, Llc Flow batteries incorporating active materials containing doubly bridged aromatic groups

Also Published As

Publication number Publication date
GB1129029A (en) 1968-10-02
NL152845B (nl) 1977-04-15
CH499487A (de) 1970-11-30
FR1513909A (fr) 1968-02-16
AT272306B (de) 1969-07-10
FI52335C (fi) 1977-08-10
FI52335B (fr) 1977-05-02

Similar Documents

Publication Publication Date Title
FI52335B (fr)
FR1552851A (fr)
AU5917865A (fr)
AU424443B2 (fr)
AU428063B2 (fr)
AU433222B2 (fr)
AU414526B2 (fr)
AU421822B2 (fr)
AU417216B2 (fr)
AU415165B1 (fr)
AU218666A (fr)
AU6703465A (fr)
AU612166A (fr)
AU5895065A (fr)
AU1111066A (fr)
AU1144366A (fr)
BE693723A (fr)
BE693495A (fr)
BE693406A (fr)
AU433620A (fr)
BE693037A (fr)
BE692901A (fr)
BE693804A (fr)
BE690842A (fr)
BE694073A (fr)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: BOEHRINGER